Agilent Posts Double-Digit Growth in Q1 Mass Spec Sales, Highlights Diagnostic Ambitions
February 17, 2012
Agilent Posts Double-Digit Growth in Q1 Mass Spec Sales, Highlights Diagnostic Ambitions
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay
March 29, 2013 / ProteoMonitor - At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases
January 11, 2013 / ProteoMonitor - At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor - Mass Spec Vendors Offer Takes on Top-Down Proteomics, UHPLC at UBS Conference
September 23, 2011 / ProteoMonitor - New Bruker Mass Spec Machine Leads Product Releases at Quiet Pittcon 2011
March 18, 2011 / ProteoMonitor